20/20 Biolabs Inc. Common Stock (AIDX)
Stock · NASDAQ · Health Care
$0.2607as of 10/16/2026
Price chart
Active signals
BOLL Breakdown68.4%
High Beta64.7%
Resistance level
$0.50325
Industry
Precision Instruments
About AIDX
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups.…
- Sector
- Health Care
- Industry
- Precision Instruments
- Employees
- 4
- Website
- 2020gene.com/
Fundamentals
- 1-day range
- $0.2606$0.28
- Market cap
- $5.54M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-0.93
- Dividend yield
- —
- Beta
- 2.42
- Avg. volume
- 95.2K
52-week range
$0.2737$50
Forecasts
1 analyst ratings
Buy 86%
Hold 14%
Sell 0%
1-year price forecast
High
$5
+1817.9%
Median
$5
+1817.9%
Low
$5
+1817.9%
20/20 Biolabs Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- AIDX20/20 Biolabs Inc. Common Stock$0.26▼ 7.14%Market cap $5.54MP/E —$0.2737$50
- VIVSVivoSim Labs Inc. Common Stock$0.16▼ 5.88%Market cap $5.53MP/E —$0.1495$3.4
- CURXCuranex Pharmaceuticals Inc Common Stock$4.62▼ 4.35%Market cap $5.53MP/E —$3.58$16.94
- BCABBioAtla Inc. Common Stock$1.36▲ 4.62%Market cap $5.53MP/E —$1.07$71.5
- NCNANuCana plc American Depositary Share$0.99▼ 2.94%Market cap $5.66MP/E 0.01$0.9484$6.1
- NDRAENDRA Life Sciences Inc. Common Stock$4.74▼ 7.06%Market cap $5.68MP/E —$2.96$8
- BGMSBio Green Med Solution Inc. Common Stock$0.91▲ 9.64%Market cap $5.35MP/E —$0.5664$6.11
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AIDX 20/20 Biolabs Inc. Common Stock | $5.54M | — | $0.26 | ▼ 7.14% | $0.2737$50 |
| VIVS VivoSim Labs Inc. Common Stock | $5.53M | — | $0.16 | ▼ 5.88% | $0.1495$3.4 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $5.53M | — | $4.62 | ▼ 4.35% | $3.58$16.94 |
| BCAB BioAtla Inc. Common Stock | $5.53M | — | $1.36 | ▲ 4.62% | $1.07$71.5 |
| NCNA NuCana plc American Depositary Share | $5.66M | 0.01 | $0.99 | ▼ 2.94% | $0.9484$6.1 |
| NDRA ENDRA Life Sciences Inc. Common Stock | $5.68M | — | $4.74 | ▼ 7.06% | $2.96$8 |
| BGMS Bio Green Med Solution Inc. Common Stock | $5.35M | — | $0.91 | ▲ 9.64% | $0.5664$6.11 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/9/2026
- 20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026Yahoo · 10/2/2026
- 20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise ModelYahoo · 9/29/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 9/25/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 300.4K
- Total value held
- $564.8K
- Institutional holders
- 7
Top holders this quarter
- Unknown264.4K
- Unknown16.2K
- Unknown10.3K
- Unknown8.3K
- Unknown1.0K
- Unknown157
- Unknown30
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
20/20 BioLabs Sets October Dates for FDA Vote and Investor Updates
20/20 BioLabs has scheduled an investor webinar for October 7, 2026, to discuss an upcoming FDA Advisory Committee vote and its new OneTest franchise model. The company will also take part in the Maxim Growth Summit in New York on October 14, 2026. These events provide key upcoming touchpoints for the stock, which currently trades near its 52-week low.
20/20 BioLabs Sets October Dates for FDA Vote and Investor Updates. 20/20 BioLabs has scheduled an investor webinar for October 7, 2026, to discuss an upcoming FDA Advisory Committee vote and its new OneTest franchise model. The company will also take part in the Maxim Growth Summit in New York on October 14, 2026. These events provide key upcoming touchpoints for the stock, which currently trades near its 52-week low.